Back to Rankings

ACH

Accendra HealthB
NYSE / Health Care Equipment & Services
Last Price
At close
2026-07-22
View Chart
Current thesis
Bull case is that the business has moved past the worst of the portfolio reshaping, 1Q results were in line with expectations, management reaffirmed full-year revenue and EBITDA guidance, and the balance-sheet reset lowers the near-term solvency discount [#SEC-8K-2026-05-11] [#PR-EARNINGS-2026-05-12].
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Debt reduction helps, but the story remains highly levered and dependent on clean execution of the balance-sheet optimization transaction [#SEC-8K-2026-05-11] [#SEC-8K-2026-05-22].
Momentum
78
Value
55
Sentiment
52
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.10 · Bull $4.40 · Bear $1.60
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-22 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-04 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $4.94
Why
Momentum78 · Δ7d -3.1
Value55 · Δ7d +0.0
Sentiment52 · Δ7d +4.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
78
26% active weight
Current posture
7d trendFlat
Δ7d
-3.1
Δ21d
+7.1
Value
55
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.1
Sentiment
52
34% active weight
Current posture
7d trendImproving
Δ7d
+4.3
Δ21d
-1.8
Why this grade

Composite grade B. Momentum 78.3 / Value 55.0 / Sentiment 51.9

Fundamentals (TTM)
As of 2026-07-22
Market Cap
$242M
Beta
1.38
Shares Out
76.58M
P/E (TTM) · Derived
-0.2
P/S (TTM)
0.02
P/FCF (TTM) · Derived
-0.83
Rev YoY
-6.8%
EPS YoY
-73.8%
Gross Margin
+41.3%
Op Margin
-4.1%
Net Debt
$1.88B
Current Ratio
0.49
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology